Analysis of the Immunochemistry Market in Malaysia

Analysis of the Immunochemistry Market in Malaysia

Major Trends in the Domestic Market

RELEASE DATE
20-Aug-2015
REGION
Asia Pacific
Research Code: 9AB9-00-38-00-00
SKU: HC02467-AP-MR_16588

$1,500.00

Special Price $1,125.00 save 25 %

In stock
SKU
HC02467-AP-MR_16588

$1,500.00

$1,125.00 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

The Malaysian immunochemistry market is dominated by Roche, Siemens, and Beckman Coulter. Other participants are Becton Dickenson, Abbott, Sysmex, and some Chinese companies. The demand for immunochemistry tests in tertiary care hospitals is high. Automated equipment is preferred but some tier I and II hospitals operate on semi-automated chemistry analyzers. Public hospitals procure equipment using tenders, while reagents are purchased in batches 2–3 times a year. The demand for immunochemistry tests will grow, as communicable disease testing has increased and preventive tests are common.

Table of Contents

Executive Summary

Executive Summary (continued)

Scope and Segmentation

Overview of Healthcare Expenditure in Malaysia

Overview of Healthcare Expenditure in Malaysia

Overview of Healthcare Expenditure in Malaysia

Growing Demand for and Affordability of Quality Healthcare Services

Growth in Malaysian Hospitals

Parallel Public and Private Healthcare Sectors in Malaysia

Division into 4 major types that facilitate the healthcare ecosystem

Access to Public Secondary and Tertiary Service Care

Principal Cause of Death in Public Hospitals

Principal Cause of Death in Private Hospitals

Malaysian Hospitals—Market Overview

Category High Public Hospitals (>650 Beds per Hospital)—Key States

Category Medium Public Hospitals (150–650 Beds)—Key States

Category Low Public Hospitals (< 150 Beds)—Key States

Category Low Public Hospitals (< 150 Beds)—Key States (continued)

Malaysian IVD Market—Market Segmentation

Malaysian Immunochemistry Market —Customer Segmentation and Customer Expenditure Pattern

Immunochemistry Market—Revenue Forecast

Clinical Chemistry Market—Revenue Forecast

Immunoassay Market—Revenue Forecast

Immunoassay Market—Revenue Forecast by Segment

Top 3 Immunochemistry Tests in Demand in Malaysian Hospitals

Usage Pattern of Immunochemistry Equipment

Future Demand for Immunochemistry Tests After GST Implementation

Demand for Automated Immunochemistry Equipment Versus Conventional—End User’s Perspective

Procurement Process of Immunochemistry Equipment in Public Hospitals

Procurement Process of Immunochemistry Reagents in Malaysian Public Hospitals

Procurement Process of Immunochemistry Equipment in Private Hospitals and Diagnostic Laboratories

Overview of Key Competitors in the Immunochemistry Market in Malaysia

Demand for Immunochemistry Equipment in Malaysia—A Distributor’s Perspective

Key Global Companies—Roche

Key Global Companies—Siemens (Healthcare)

Key Global Companies—Abbott

Key Global Companies—Becton Dickinson

Key Local Companies—BP Healthcare

Top 3 Competitors—Immunochemistry Equipment Manufacturers

Segment Analysis of Competitors in the Immunochemistry Market

Key Distributors in the Malaysian Immunochemistry Market

Opportunity for Automated Equipment Manufacturers

New Public Hospitals in Malaysia

New Private Hospitals in Malaysia

Key Market Drivers

Key Market Restraints

Future Trends in the Malaysian Immunochemistry Market

Category Low Public Hospitals (< 150 beds)—Other States

Category Low Public Hospitals (< 150 beds)—Other States

Category Medium Public Hospitals (150 beds-650 beds)—Other States

Category High Public Hospitals (>650 beds)—Other States

Legal Disclaimer

The Frost & Sullivan Story

Value Proposition

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

Related Research
The Malaysian immunochemistry market is dominated by Roche, Siemens, and Beckman Coulter. Other participants are Becton Dickenson, Abbott, Sysmex, and some Chinese companies. The demand for immunochemistry tests in tertiary care hospitals is high. Automated equipment is preferred but some tier I and II hospitals operate on semi-automated chemistry analyzers. Public hospitals procure equipment using tenders, while reagents are purchased in batches 2–3 times a year. The demand for immunochemistry tests will grow, as communicable disease testing has increased and preventive tests are common.
More Information
No Index No
Podcast No
Author Siddharth Dutta
Industries Healthcare
WIP Number 9AB9-00-38-00-00
Is Prebook No